Richard Michael John Palmer

RICHARD MICHAEL JOHN PALMER is Chief Executive Officer of Alizyme Plc.
Dr. Palmer joined the company in September 1996 and has been Chief
Executive Officer of Alizyme since March 1997 and also retains overall
responsibility for research and development. Previously at Wellcome and
Glaxo Wellcome, he has 30 years’ experience of research and development
management.